You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunoglobulin Light-chain Amyloidosis

Showing 1 - 25 of 6,564
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules

Not yet recruiting
  • Immunoglobulin Light-chain Amyloidosis
  • Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
  • (no location specified)
Mar 18, 2023

Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis Trial (SAR445514)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Amyloid Light-chain Amyloidosis
  • (no location specified)
Apr 20, 2023

Clinical Study for AL-CM

Recruiting
  • Immunoglobulin Light Amyloidosis Cardiomyopathy
  • current treatment of AL-CM
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jan 29, 2023

Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)

Recruiting
  • Amyloid
  • Amyloid Cardiomyopathy
  • 18F-florbetaben PET/CT
  • Pisa, Italy
    Fondazione Toscana Gabriele Monasterio
Sep 16, 2023

AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)

Not yet recruiting
  • AL Amyloidosis
  • Bone Marrow Biopsy
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Jun 2, 2023

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

Light Chain (AL) Amyloidosis Trial (STI-6129)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • (no location specified)
Jan 11, 2023

Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

Suspended
  • Amyloid
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
May 17, 2022

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

AL Amyloidosis Trial in Catanzaro, Pavia, Rome (daratumumab and pomalidomide)

Recruiting
  • AL Amyloidosis
  • daratumumab and pomalidomide
  • Catanzaro, Italy
  • +2 more
Aug 3, 2022

AL Amyloidosis Trial in Pavia

Recruiting
  • AL Amyloidosis
    • Pavia, Italy
      Fondazione IRCCS Policlinico San Matteo
    May 4, 2022

    AL Amyloidosis Trial in Beijing

    Recruiting
    • AL Amyloidosis
      • Beijing, China
        Peking Union Medical College Hospital
      Apr 20, 2022

      AL Amyloidosis Trial in Palo Alto, Detroit, Cleveland (CAEL-101, SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD),

      Active, not recruiting
      • AL Amyloidosis
      • Palo Alto, California
      • +2 more
      Dec 6, 2022

      Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

      Active, not recruiting
      • Multiple Myeloma
      • AL Amyloidosis
      • Siltuximab
      • The M.D. Anderson Symptom Inventory (MDASI)
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 23, 2023

      Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

      Active, not recruiting
      Has Results
      • Primary Systemic Amyloidosis
      • Light Chain Deposition Disease
      • Denver, Colorado
      • +6 more
      Aug 24, 2022

      AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

      Not yet recruiting
      • AL Amyloidosis
      • Venetoclax Oral Tablet, 200 mg
      • +9 more
      • New York, New York
        New York Presbyterian Hospital/Columbia University Irving Medica
      Jul 11, 2022

      Amyloidosis, AL Amyloidosis Trial in Worldwide (ZN-d5)

      Recruiting
      • Amyloidosis
      • AL Amyloidosis
      • Denver, Colorado
      • +1 more
      Jan 18, 2022

      AL Amyloidosis Trial in Worldwide (Belantamab mafodotin)

      Recruiting
      • AL Amyloidosis
      • Belantamab mafodotin
      • Limoges, France
      • +5 more
      Sep 26, 2022

      Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)

      Terminated
      • Amyloidosis; Systemic
      • Propylene Glycol-Free Melphalan Hydrochloride
      • Boston, Massachusetts
        Boston Medical Center
      Jul 1, 2022

      Cardiac Amyloidosis Screening at Trigger Finger Release

      Completed
      • Amyloidosis
      • +3 more
      • Biopsy
      • Cleveland, Ohio
        Cleveland Clinic
      Dec 21, 2021

      Hereditary Transthyretin Amyloidosis

      Recruiting
      • Amyloidosis
      • +6 more
        • Cleveland, Ohio
          Cleveland Clinic
        Mar 11, 2022

        Cardiac Amyloidosis, AL Amyloidosis, ATTR Amyloidosis Trial ([18F]florbetaben)

        Not yet recruiting
        • Cardiac Amyloidosis
        • +2 more
        • (no location specified)
        Apr 22, 2022

        Screening for Systemic Amyloidosis Via the Ligamentum Flavum

        Completed
        • Amyloid
        • +4 more
        • Biopsy
        • Cleveland, Ohio
          Cleveland Clinic
        Dec 21, 2021